16-3242361-CAAAAAAA-CA
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BS1BS2
The NM_000243.3(MEFV):c.*774_*779delTTTTTT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00907 in 73,060 control chromosomes in the GnomAD database, including 5 homozygotes. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0091 ( 5 hom., cov: 22)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
MEFV
NM_000243.3 3_prime_UTR
NM_000243.3 3_prime_UTR
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.338
Publications
0 publications found
Genes affected
MEFV (HGNC:6998): (MEFV innate immunity regulator, pyrin) This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. [provided by RefSeq, Jul 2008]
MEFV Gene-Disease associations (from GenCC):
- familial Mediterranean feverInheritance: AD, AR, SD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, ClinGen
- autosomal recessive familial Mediterranean feverInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- familial Mediterranean fever, autosomal dominantInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00907 (663/73060) while in subpopulation AFR AF = 0.0298 (628/21050). AF 95% confidence interval is 0.0279. There are 5 homozygotes in GnomAd4. There are 338 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR,AD,SD gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00906 AC: 662AN: 73050Hom.: 5 Cov.: 22 show subpopulations
GnomAD3 genomes
AF:
AC:
662
AN:
73050
Hom.:
Cov.:
22
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 236Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 166
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
236
Hom.:
AF XY:
AC XY:
0
AN XY:
166
African (AFR)
AC:
0
AN:
0
American (AMR)
AF:
AC:
0
AN:
4
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
AC:
0
AN:
6
South Asian (SAS)
AF:
AC:
0
AN:
134
European-Finnish (FIN)
AF:
AC:
0
AN:
8
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
0
AN:
84
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome AF: 0.00907 AC: 663AN: 73060Hom.: 5 Cov.: 22 AF XY: 0.00988 AC XY: 338AN XY: 34216 show subpopulations
GnomAD4 genome
AF:
AC:
663
AN:
73060
Hom.:
Cov.:
22
AF XY:
AC XY:
338
AN XY:
34216
show subpopulations
African (AFR)
AF:
AC:
628
AN:
21050
American (AMR)
AF:
AC:
24
AN:
6106
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2102
East Asian (EAS)
AF:
AC:
0
AN:
2852
South Asian (SAS)
AF:
AC:
0
AN:
2304
European-Finnish (FIN)
AF:
AC:
0
AN:
2558
Middle Eastern (MID)
AF:
AC:
0
AN:
80
European-Non Finnish (NFE)
AF:
AC:
1
AN:
34676
Other (OTH)
AF:
AC:
10
AN:
926
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.554
Heterozygous variant carriers
0
23
46
68
91
114
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.